News Conference News ESOC 2025 IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK Todd Neale May 22, 2025
News Daily News Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention Michael O'Riordan May 07, 2025
News Conference News ACC 2025 RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI Michael O'Riordan April 02, 2025
News Daily News Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives L.A. McKeown March 03, 2025
News Daily News More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin L.A. McKeown February 14, 2025
News Daily News Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist Todd Neale January 15, 2025
News Daily News CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy Todd Neale December 04, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024
News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News CVD Risk Twofold Higher in Patients With Cancer: ASPREE Michael O'Riordan September 27, 2024
News Conference News ESC 2024 Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events Michael O'Riordan September 01, 2024
News Conference News ESC 2024 Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD Todd Neale September 01, 2024
News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Daily News No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data Yael L. Maxwell July 15, 2024